The reagent kit Immunochromatographic test system for the qualitative detection of IgM / IgG antibodies to SARS-CoV-2 coronavirus in human serum, plasma or whole blood samples SARS-CoV-2 IgM/IgG Screen is intended for one-stage rapid qualitative detection IgM and / or IgG to SARS-CoV-2 coronavirus in human serum, plasma or whole blood samples in individuals with clinical symptoms of respiratory disease with suspected COVID-19 infection, as well as in individuals who do not have signs of colds and are not contact with patients with COVID-2019 by the method of immunochromatographic analysis (LFIA).
Functional purpose:
The kit is used as an aid in the diagnosis. Antibody test results should not be used as the sole basis for confirming or excluding SARS-CoV-2 infection, or for reporting infection status.
For single use of the test for its intended use.
For clinical In Vitro Diagnostics.
